from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3320c/vapC44

LFCtreatmentdescriptionclass of inhibitor

-0.420

Amikacinug/mL Amikacintranslation

0.573

Cap5-10ug/mL Capreomycintranslation

0.101

Rox10-50 ug/mL Roxithromycintranslation

0.655

SM2-5 ug/mL Streptomycintranslation

1.558

Tet5-10 ug/mL Tetracyclinetranslation

0.240

Rif0.2-5ug/mL Rifampicintranscription

-0.054

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.573

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.566

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.383

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.796

Clofazimine10-13 ug/mL Clofaziminerespiration

0.427

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.821

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.057

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.783

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.142

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.889

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.037

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.437

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.389

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.425

KCN5-20 ug/mL Potassium cyaniderespiration

0.339

NaN30.2-2 mM Sodium aziderespiration

0.594

Nigericin50 uM Nigericinrespiration

-0.049

TRC10-150 ug/mL Triclosanrespiration

-0.850

TRZ10-25 ug/mL Thioridazinerespiration

-1.237

Valinomycin0.5-10 uM Valinomycinrespiration

0.886

ZnSO42 mM ZnSO4respiration

0.856

menadione6-10 ug/mL Menadionerespiration

-0.775

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.194

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.823

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.985

NRP_1Non-replicating persistence stage 1dosRassociated

0.833

Amp0.2mg/mL AmpicillincellWall

0.512

Cephalexin20-100 ug/mL CephalexincellWall

0.865

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.017

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.405

EMB10-20 ug/mL EthambutolcellWall

0.334

Eta12-40 ug/mL EthionamidecellWall

-0.044

INH0.2-0.4 ug/mL IsoniazidcellWall

0.282

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.052

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.732

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.331

BZA0.12 mg/mL BenzamidearomaticAmides

0.219

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.446

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.231

H2O24 mM hydrogen peroxideDNAdamaging

-0.053

Levo10 ug/mL LevofloxacinDNAdamaging

0.514

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.215

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.335

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.145

UVUV-irradiationDNAdamaging

-1.790

ARP41-4 ug/mL Antitubercular compound ARP4?

0.137

Antimycin12.5-50 ug/mL Antimycin A?

0.784

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.857

PA_110-50 ug/mL Antitubercular compound PA-1?

0.680

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.186

PA8240.2-2 ug/mL PA-824?

-0.323

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.151

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.097

Verapamil50 uM Verapamil?

0.209

mercaptoethanol2 mM 2-Mercaptoethanol?

1.266

methoxatin10-20 ug/mL Methoxatin?